india-business -

Goldman Backs Clarity Act

similispharma@gmail.comJuly 28, 20260

Business NewsBy Kavita NairJuly 28, 20268 min read Key Takeaways Goldman backs Clarity Act Democrats criticize bill Warren rejects legislation…

similispharma@gmail.comJuly 16, 20260

Stock MarketBy Priya SharmaJuly 16, 20267 min read Key Takeaways Inflation concerns drive market volatility RBI decisions impact stock prices…

similispharma@gmail.comJuly 4, 20260

StartupsBy Priya SharmaJuly 4, 20268 min read Key Takeaways Investments surge 25% in India's startup ecosystem Funding reaches $10 billion…

similispharma@gmail.comJuly 2, 20260

StartupsBy Arjun MehtaJuly 2, 20267 min read Key Takeaways Investors flock to Bloom Energy's AI infrastructure expansion Brookfield invests $1.5…

similispharma@gmail.comMay 26, 20260

StartupsBy Arjun MehtaMay 26, 20267 min read Key Takeaways Analysts upgrade A. O. Smith's stock ratings. Investors drive stock prices…

similispharma@gmail.comApril 10, 20260

The dollar, long considered a safe-haven asset, has been losing its war premium of late, and emerging markets are rejoicing…

similispharma@gmail.comApril 10, 20260

India’s Entrepreneurial Landscape Set to Benefit from Shell’s Rosy Forecast As India continues to navigate the complexities of a rapidly…

similispharma@gmail.comApril 9, 20260

As the cryptocurrency market continues to experience an unprecedented surge, a telling sign emerged this week – the outflows into…

similispharma@gmail.comApril 5, 20260

As the world rapidly shifts towards automation, artificial intelligence (AI) has emerged as the most sought-after technology in the startup…

similispharma@gmail.comApril 1, 20260

As the first-quarter earnings season draws to a close, the global stock market is staging a remarkable turn of events….